These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Aminooxyacetic acid produces excitotoxic lesions in the rat striatum. Urbańska E; Ikonomidou C; Sieklucka M; Turski WA Synapse; 1991 Oct; 9(2):129-35. PubMed ID: 1821484 [TBL] [Abstract][Full Text] [Related]
9. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Brouillet EP; Shinobu L; McGarvey U; Hochberg F; Beal MF Exp Neurol; 1993 Mar; 120(1):89-94. PubMed ID: 8477830 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism. Abdin AA; Hamouda HE Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789 [TBL] [Abstract][Full Text] [Related]
11. Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen. Midgley LP; Bush LG; Gibb JW; Hanson GR Brain Res; 1992 Oct; 593(1):89-96. PubMed ID: 1360868 [TBL] [Abstract][Full Text] [Related]
13. Age-dependent neurotoxicity of striatal lesions produced by aminooxyacetic acid: quantitative in vitro 1H NMR spectroscopic studies. Chang C; Jang T J Neurochem; 1995 Sep; 65(3):1192-8. PubMed ID: 7643097 [TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Matthews RT; Yang L; Browne S; Baik M; Beal MF Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8892-7. PubMed ID: 9671775 [TBL] [Abstract][Full Text] [Related]
15. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum. Zeevalk GD; Manzino L; Sonsalla PK Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083 [TBL] [Abstract][Full Text] [Related]
16. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases. Beal MF; Matthews RT Mol Aspects Med; 1997; 18 Suppl():S169-79. PubMed ID: 9266519 [TBL] [Abstract][Full Text] [Related]
17. Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Schulz JB; Henshaw DR; Matthews RT; Beal MF Exp Neurol; 1995 Apr; 132(2):279-83. PubMed ID: 7789466 [TBL] [Abstract][Full Text] [Related]
18. Comparative influence of kolaviron and coenzyme Q10 on complex I activity, glutamate clearance, 3,4-dihydroxyphenethylamine metabolism, and redox stress in rotenone-induced neurotoxicity. Akinmoladun AC; Saliu I; Abilogun O; Ajibola OH; Amoo ZA; Ojo OB; Farombi EO; Olaleye MT Niger J Physiol Sci; 2022 Dec; 37(2):165-173. PubMed ID: 38243568 [TBL] [Abstract][Full Text] [Related]
19. Behavioral and pharmacological effects of centrally administered aminooxyacetic acid in rats. Vécsei L; Beal MF Eur J Pharmacol; 1992 Sep; 220(2-3):259-62. PubMed ID: 1385183 [TBL] [Abstract][Full Text] [Related]
20. Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Ferrante RJ; Schulz JB; Kowall NW; Beal MF Brain Res; 1997 Apr; 753(1):157-62. PubMed ID: 9125443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]